Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZGNX

Zogenix (ZGNX) Stock Price, News & Analysis

Zogenix logo

About Zogenix Stock (NASDAQ:ZGNX)

Advanced Chart

Key Stats

Today's Range
$26.68
$26.68
50-Day Range
$26.10
$26.68
52-Week Range
$11.03
$26.90
Volume
94 shs
Average Volume
3.76 million shs
Market Capitalization
$1.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZGNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zogenix and its competitors with MarketBeat's FREE daily newsletter.

ZGNX Stock News Headlines

Hwasung Industrial Co Ltd 002460
ThinkorSwim founder's 389% winner (exclusive access)
389% in 48 hours. SPX 500%. VIX 67%. These are real trades — not backtests — made live in front of thousands. Now the team behind those results is offering a bold experiment: full access to their live trading room, and you name the price. No $2,000 paywall. No pressure. Just proven traders, real-time decisions… and one free trade to get started.
Alcon (NYSE: ALC)
Longeveron Inc Ordinary Shares - Class A
Biocryst Pharmaceuticals
See More Headlines

ZGNX Stock Analysis - Frequently Asked Questions

Zogenix, Inc. (NASDAQ:ZGNX) announced its quarterly earnings data on Thursday, November, 4th. The company reported ($1.04) EPS for the quarter, missing analysts' consensus estimates of ($0.96) by $0.08. The firm's quarterly revenue was up 690.6% on a year-over-year basis.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zogenix investors own include Bristol Myers Squibb (BMY), QUALCOMM (QCOM), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH), Intel (INTC), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/04/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ZGNX
CIK
1375151
Employees
218
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$209.38 million
Net Margins
-278.38%
Pretax Margin
-278.26%
Return on Equity
-91.20%
Return on Assets
-43.60%

Debt

Debt-to-Equity Ratio
0.88
Current Ratio
3.63
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$81.69 million
Price / Sales
18.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.64 per share
Price / Book
4.02

Miscellaneous

Outstanding Shares
56,227,000
Free Float
53,922,000
Market Cap
$1.50 billion
Optionable
Optionable
Beta
0.89
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ZGNX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners